Abanan, Mary Joy H.
HRN: 22-82-16 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/25/2023
CEFUROXIME 500MG (TAB)
05/25/2023
06/01/2023
PO
500mg
BID X 7 Days
Pus Cells: 10-12, Bacteria: Moderate
Checking Final Appropriateness
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes